Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - A critical analysis;Testes de sensibilidade à pirazinamida em todos os isolados do complexo Mycobacterium tuberculosis - Uma análise crítica

Revista Portuguesa de Pneumologia

Volumn 18, Issue 4, 2012, Pages 188-189

  Cunha, J ^a  

^a Administracao Regional de Saude do Norte   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE;

EID: 84869864787     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppneu.2011.12.002     Document Type: Note

References (15)

1. Expert Committee on Tuberculosis - report on the fifth edition 1950, World Health Organization, WHO, Genebra.
2. O'Reilly L.M., Daborn C.J. The epidemiology of Mycobacterium bovis infection in animals and man: a review. Tuber Lung Dis 1995, 76:1-46.
3. Majoor C.J., Magis-Escurra C., van Ingen J., Boeree M.J., van Soolingen D. Epidemiology of Mycobacterium bovis disease in humans, the Netherlands, 1993-2007. Emerg Infect Dis 2011, 17:457-463.
4. de la Rua-Domenech R. Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis 2006, 86:77-109.
5. Ingram P.R., Bremner P., Inglis T.J., Murray R.J., Cousins D.V. Zoonotic tuberculosis: on the decline. Commun Dis Intell 2010, 34:339-341.
6. Rodríguez E., Sánchez L.P., Pérez S., Herrera L., Jiménez M.S., Samper S., et al. Human tuberculosis due to Mycobacterium bovis and M. caprae in Spain, 2004-2007. Int J Tuberc Lung Dis 2009, 13:1536-1541.
7. Hlavsa M.C., Moonan P.K., Cowan L.S., Navin T.R., Kammerer J.S., Morlock G.P., et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin Infect Dis 2008, 15:168-175.
8. David S., Portugal C., Antunes A., Cardoso A., Calado A., Barros V., et al. Molecular identification using Spoligotyping of strains from the Mycobacterium tuberculosis complex isolated from the Hospital Fernando Fonseca. Rev Port Pneumol 2004, 10:195-204.
9. David S., Portugal C., Antunes A., Calado A., Cardoso A., Barros V., et al. Spoligotyping and pncA polymorphism: a two step scenario for Mycobacterium bovis diagnosis in Portugal. Rev Port Pneumol 2005, 11:533-556.
10. Direcção Geral de Saúde. Vigilância da tuberculose zoonótica por Mycobacterium bovis em seres humanos. Orientação n° 13/2010 de 7-12-2010.
11. Direcção Geral de Saúde. Resistência aos antibióticos em Tuberculose. Circular Normativa n° 9/DT de 29-05-2000.
12. Mastering the basics of TB control: Development of a handbook on TB diagnostic methods 2011, European Centre for Disease Prevention and Control, ECDC, Stockholm.
13. a ed. WHO/HTM/TB/2009.422.
14. de Jong B.C., Onipede A., Pym A.S., Gagneux S., Aga R.S., DeRiemer K., et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?. J Clin Microbiol 2005, 43:3530-3532.
15. Kubica T., Agzamova R., Wright A., Rakishev G., Rüsch-Gerdes S., Niemann S. Mycobacterium bovis isolates with M. tuberculosis specific characteristics. Emerg Infect Dis 2006, 12:763-765.